Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence in molecular diagnostics for pandemic preparedness.

Expert review of molecular diagnostics·2026
Same author

Ethical Challenges in Journal Publishing: Policies and Approaches.

Journal of advances in medical education & professionalism·2026
Same author

Designing and Psychometric Evaluation of Professional Competency Assessment Tools in Educating Accident and Emergency Managers.

Journal of advances in medical education & professionalism·2026
Same author

Modeling Factors Affecting Physicians' Acceptance of E-Prescriptions Using Structural Equation Modeling-Partial Least Squares Analysis: A Cross-Sectional Study.

Health science reports·2026
Same author

Predicting Prolonged Hospital Length of Stay in Trauma Patients Using Machine Learning Techniques: A Cross-Sectional Study.

Health science reports·2026
Same author

Mobile health applications for parents of children with Hirschsprung disease: a requirement analysis.

European journal of pediatrics·2026

Related Experiment Video

Updated: Jun 5, 2025

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq
04:54

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq

Published on: March 19, 2021

4.5K

Developing and validating a content quality evaluation tool for cancer mobile applications.

Najmeh Ashkani1, Leila Erfannia2, Rita Rezaee2

  • 1Department of Health Information Management, School of Health Management and Information Sciences, Student Research Committee, Health Human Resources Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

BMC Cancer
|December 5, 2024
PubMed
Summary

This study developed and validated a tool to assess cancer mobile app quality. The tool ensures apps offer standard services, aiding patients in selecting high-quality cancer care resources.

Keywords:
CancerEvaluationMobile applicationsMobile health

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

381

Related Experiment Videos

Last Updated: Jun 5, 2025

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq
04:54

Iterative Development of an Innovative Smartphone-Based Dietary Assessment Tool: Traqq

Published on: March 19, 2021

4.5K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

381

Area of Science:

  • Health Informatics
  • Mobile Health (mHealth)
  • Oncology

Background:

  • Cancer remains a major cause of mortality globally.
  • The proliferation of mobile health applications necessitates quality evaluation.
  • Reliable cancer mobile apps are crucial for supporting patient care.

Purpose of the Study:

  • To design and validate a content quality evaluation tool for cancer mobile applications.
  • To ensure cancer apps provide standard, high-quality services and features.
  • To assist health policymakers and patients in identifying superior cancer-related mobile resources.

Main Methods:

  • A descriptive-analytical study involving literature and app store searches.
  • Expert panel validation with 19 oncologists and informatics specialists.
  • Assessment of tool validity and reliability using Content Validity Ratio (CVR), Content Validity Index (CVI), and Cronbach's alpha.

Main Results:

  • A validated tool with 8 themes and 43 items was developed.
  • All items met validity thresholds (CVI > 0.79, CVR > 0.42).
  • The tool demonstrated high reliability with a Cronbach's alpha of 0.967.

Conclusions:

  • The developed tool is effective for evaluating cancer mobile application quality.
  • It can guide the development of supportive and useful cancer mHealth tools.
  • Facilitates informed choices for patients, improving overall cancer care quality.